Ligand validation:3EIA

PL6: (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-glutamic acid

PL6 is a Ligand Of Interest in 3EIA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EIA_PL6_B_433	83%	12%	0.116	0.976	1.97	2.09	6	9	0	0	100%	1
3EIA_PL6_A_434	58%	4%	0.167	0.946	2.8	2.84	9	9	0	0	100%	1
3EI9_PL6_B_433	83%	32%	0.097	0.954	1.56	1.17	6	1	0	0	100%	1
5VWR_PL6_A_501	84%	2%	0.109	0.972	4.24	2.38	7	5	0	1	100%	1
6JC8_PL6_C_601	73%	17%	0.145	0.972	1.31	2.28	3	13	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.